Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma Edvan de Queiroz Crusoé, Flávia Cristina Fernandes Pimenta, Angelo Maiolino, Nelson Siqueira de Castro, Huiling Pei, Damila Trufelli, Mariana Fernandez, Luciana Barreto Herriot

SAFETY OF DARATUMUMAB IN FRAIL PATIENTS WITH MULTIPLE MYELOMA TX Carneiro, JLS Sales, LDS Pimentel, LG Fonseca, LBC Leão, MEL Araújo, NS Moraes

Daratumumab-EPOCH for transformed anaplastic multiple myeloma Espen Stormorken, Anders Erik Astrup Dahm